Barclays Downgrades Qiagen to Equal-Weight, Lowers Price Target to $53

Benzinga · 5d ago
Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and lowers the price target from $55 to $53.